Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

Thrombosis and Haemostasis

Volumn 109, Issue 5, 2013, Pages 956-960

  Roldán, Vanessa ^a   Marín, Francisco ^b   Manzano Fernández, Sergio ^b   Fernández, Hermógenes ^a   Gallego, Pilar ^a   Valdés, Mariano ^b   Vicente, Vicente ^a   Lip, Gregory Y H ^c  

^a HOSPITAL MORALES MESEGUER   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; Chronic kidney disease; Mortality; Stroke

Indexed keywords

ACENOCOUMAROL;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CHRONIC KIDNEY DISEASE; EMBOLISM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; TRANSIENT ISCHEMIC ATTACK;

ACENOCOUMAROL; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KIDNEY; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877062263     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-01-0054     Document Type: Article

References (27)

1. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001; 285: 2864-2870
2. 2 score for stroke risk stratification in atrial fibrillation--friend or foe? Thromb Haemost 2010; 104: 45-48
3. Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor- based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272
4. Lip GY. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur Heart J 2012; Epub ahead of print.
5. 2 score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Rev Esp Cardiol 2012; 65: 627-633
6. Marinigh R, Lane DA, Lip GY. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. J Am Coll Cardiol 2011; 57: 1339-1348
7. Go AS, Fang MC, Udaltsova N, et al.; ATRIA Study Investigators. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009; 119: 1363-1369
8. Nakagawa K, Hirai T, Takashima S, et al. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation. Am J Cardiol 2011; 107: 912-916
9. Olesen JB, Lip GY, Kamper AL, et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012; 367: 625-635
10. Fujii H, Kim JI, Yoshiya K, et al. Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: a prospective follow-up study. Am J Nephrol 2011; 34: 126-134
11. Roldán V, Marín F, Fernández H, et al. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol 2013; Epub ahead of print.
12. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
13. Levey AS, Coresh J, Greene T, et al.; Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
14. National Kidney Foundation. K/DOQI clinical practice guidelines form chronic kidney disease: evaluation, classification, and stratification. Am J Kid Dis 2012; 39: S1-S266
15. Pencina MJ, D'Agostino RB, D'Agostino RB Jr., et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172
16. Iguchi Y, Kimura K, Kobayashi K, et al. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 2008; 102: 1056-1059
17. Vázquez E, Sánchez-Perales C, Lozano C, et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003; 92: 868-871
18. 2 Index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation)Study Cohorts. Circulation 2013; 127: 224-232
19. Camm AJ, Savelieva I. R for renal and for risk: refining risk stratification for stroke in atrial fibrillation. Circulation 2013; 127: 169-171
20. Poli D, Antonucci E, Zanazzi M, et al. Impact of glomerular filtration on bleeding risk in very old patients treated with VKA: Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thromb Haemost 2012; 107: 1100-1106
21. Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest 2010; 138: 1093-1100
22. Hart RG, Pearce LA, Asinger RW, et al. Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2599-2604
23. Lip GY, Frison L, Halperin JL, et al. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010; 41: 2731-2738
24. Poli D, Lip GY, Antonucci E, et al. Stroke risk stratification in a real-world elderly anticoagulated atrial fibrillation population. J Cardiovasc Electrophysiol 2011; 22: 25-30
25. Connolly SJ, Ezekowitz MD, Yusuf S, et al., and The RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151
26. Granger CB, Alexander JH, McMurray JJ, et al.; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992
27. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. Br Med J 2011; 342: d124.